Skip to main content
Clinical Trials/CTRI/2024/04/066317
CTRI/2024/04/066317
Recruiting
Phase 3

A Prospective Randomised Controlled Trial To Compare The Stability Of Bronchial Blocker Between Extraluminal And Intraluminal Placement In Adult Thoracic Surgery - NI

Tata memorial Centre Mumbai0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: J99- Respiratory disorders in diseasesclassified elsewhere
Sponsor
Tata memorial Centre Mumbai
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Tata memorial Centre Mumbai

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients who are deemed suitable for both extraluminal as well as intraluminal placement of BB by a thoracic anaesthetist. This would typically include patients in whom a cuffed single lumen endotracheal tube of size 7\.5 or above is considered appropriate i.e. most male patients and female patients with height above 155 cm
  • 2\.Patients in whom a bronchial blocker with a fixed angle tip is chosen for lung isolation e.g. Coopdech blocker, Tappa blocker or Fuji blocker

Exclusion Criteria

  • 1\.Patients with risk of cross contamination of lung with blood or infected secretions, or those with bronchopleural fistula
  • 2\.Patients in whom EZ or Arndt blocker is used for lung isolation
  • 3\.Patients with abnormal tracheobronchial anatomy detected on radiological imaging or flexible bronchoscopy
  • 4\.Patients with an anticipated difficult airway
  • 5\.Patients with unanticipated difficult airway e.g. those requiring more than 3 attempts at endotracheal intubation, those requiring rescue measures to maintain oxygenation, etc
  • 6\.Patients belonging to ASA III physical status
  • 7\.Patients at high risk of regurgitation and aspiration
  • 8\.Patients in whom a 7F BB is unable to achieve a seal (and therefore isolation)
  • 9\.Patients who cannot give valid consent
  • 10\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials